Emend Tri-Pack 80 mg (Aprepitant CAPSULE) 80 MG

EMEND Tri-Pack 80 mg capsules combine aprepitant with other active ingredients for nausea and vomiting relief. This oral medication is designed for specific therapeutic uses, often discussed with healthcare providers.

Strength

80 MG

Pack Size

1X125MG + 2X80MG

Manufacturer / TM Owner

MERCK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

EMEND Tri-Pack 80 mg is primarily used to prevent nausea and vomiting caused by chemotherapy or surgery. The combination of aprepitant and other active ingredients targets the neurotransmitters involved in these symptoms. Patients often ask, 'What is EMEND Tri-Pack used for?'—it is typically prescribed for short-term relief in controlled settings.

Side Effects

Common effects of EMEND Tri-Pack 80 mg may include dizziness, fatigue, and constipation. Some users report mild headaches or diarrhea. These effects vary by individual and are generally temporary. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

EMEND Tri-Pack 80 mg should be handled with care, especially by those with liver conditions or taking other medications. It is important to follow the prescribed dosage and storage instructions. Pregnant or breastfeeding individuals should discuss use with a healthcare provider.

Avoid Interactions

EMEND Tri-Pack 80 mg may interact with certain medications, including CYP3A4 inhibitors or inducers. Alcohol and other sedatives might enhance drowsiness. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

EMEND Tri-Pack 80 mg is used to prevent nausea and vomiting, often related to chemotherapy or surgery.

EMEND Tri-Pack 80 mg is taken orally, typically as directed by a healthcare provider. Follow the prescribed dosage and timing.

Common side effects may include dizziness, fatigue, and constipation. These effects are usually mild and temporary.

EMEND Tri-Pack 80 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Pregnant individuals should discuss the use of EMEND Tri-Pack 80 mg with a healthcare provider to weigh the benefits and risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.